H-Guard®
Prevention of immune-mediated inflammatory reactions during hemodialysis
Pre-clinicalActive
Key Facts
Indication
Prevention of immune-mediated inflammatory reactions during hemodialysis
Phase
Pre-clinical
Status
Active
Company
About Invizius
Invizius is a private, clinical-stage medical device company targeting a critical unmet need in hemodialysis: the harmful immune reactions triggered when blood contacts the artificial surfaces of the dialysis circuit. The company's lead technology, H-Guard®, is a single-use, disposable device that aims to 'pre-condition' a patient's blood at the start of dialysis to prevent these inflammatory responses. By mitigating these reactions, Invizius aims to reduce long-term cardiovascular damage, improve patient quality of life, and lower associated healthcare costs for the growing global dialysis population.
View full company profile